INCOG BioPharma Completes Contstruction of Cleanrooms, On Track to Manufacture Injectable Drug Products in Q3 2022

FISHERS, Ind., April 5, 2022 — INCOG BioPharma Services (“INCOG”), an Indiana-based contract development and manufacturing organization (CDMO) reached another major milestone in its facility by completing the construction of its cleanroom production area within the new 90,000ft2 biopharma manufacturing site.

The fill-finish organization will be a key partner to life sciences companies that outsource the manufacturing of innovative injectable therapies. The newly completed cleanroom area within the building will feature a multi-use aseptic filling line, including fully integrated isolator technology, that can process both bulk vials and ready-to-use (RTU) vials, syringes, and cartridges. In addition, INCOG plans to conduct formulation activities, inspection, labeling, and packaging services in its recently constructed manufacturing space.

INCOG partnered with AES Clean Technology (“AES”), a leading provider of cleanroom facilities supporting the biopharmaceutical industry. AES equipped the new state-of-the-art facility in Fishers with its modular cleanroom systems and high-performance HVAC technology to optimize environmental control. 



    We would love to hear from you.

    Let’s work together.

    INCOG BioPharma Services
    12050 Exit 5 Parkway
    Fishers, IN 46037